Cardiac remodelling in the highest city in the world: effects of altitude and chronic mountain sickness.

Altitude Heart Heart remodelling Hypoxia Pulmonary artery pressure

Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
07 12 2022
Historique:
received: 09 03 2022
revised: 20 07 2022
accepted: 03 08 2022
pubmed: 6 8 2022
medline: 15 12 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

A unique Andean population lives in the highest city of the world (La Rinconada, 5100 m, Peru) and frequently develops a maladaptive syndrome, termed chronic mountain sickness (CMS). Both extreme altitude and CMS are a challenge for the cardiovascular system. This study aims to evaluate cardiac remodelling and pulmonary circulation at rest and during exercise in healthy and CMS highlanders. Highlanders living permanently at 3800 m (n = 23) and 5100 m (n = 55) with (n = 38) or without CMS (n = 17) were compared with 18 healthy lowlanders. Rest and exercise echocardiography were performed to describe cardiac remodelling, pulmonary artery pressure (PAP), and pulmonary vascular resistance (PVR). Total blood volume (BV) and haemoglobin mass were determined in all people. With the increase in the altitude of residency, the right heart dilated with an impairment in right ventricle systolic function, while the left heart exhibited a progressive concentric remodelling with Grade I diastolic dysfunction but without systolic dysfunction. Those modifications were greater in moderate-severe CMS patients. The mean PAP was higher both at rest and during exercise in healthy highlanders at 5100 m. The moderate-severe CMS subjects had a higher PVR at rest and a larger increase in PAP during exercise. The right heart remodelling was correlated with PAP, total BV, and SpO2. Healthy dwellers at 5100 m exhibit both right heart dilatation and left ventricle concentric remodelling with diastolic dysfunction. Those modifications are even more pronounced in moderate-severe CMS subjects and could represent the limit of the heart's adaptability before progression to heart failure.

Identifiants

pubmed: 35929776
pii: 6656255
doi: 10.1093/eurjpc/zwac166
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2154-2162

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: None declared.

Auteurs

Stéphane Doutreleau (S)

HP2 Laboratory, Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Avenue Kimberley, 38 434 Grenoble, France.

Mathilde Ulliel-Roche (M)

HP2 Laboratory, Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Avenue Kimberley, 38 434 Grenoble, France.

Ivan Hancco (I)

HP2 Laboratory, Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Avenue Kimberley, 38 434 Grenoble, France.

Sébastien Bailly (S)

HP2 Laboratory, Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Avenue Kimberley, 38 434 Grenoble, France.

Laura Oberholzer (L)

The Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Paul Robach (P)

HP2 Laboratory, Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Avenue Kimberley, 38 434 Grenoble, France.
National School for Mountain Sports, Site of the National School for Skiing and Mountaineering (ENSA), Chamonix, France.

Julien V Brugniaux (JV)

HP2 Laboratory, Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Avenue Kimberley, 38 434 Grenoble, France.

Aurélien Pichon (A)

Laboratoire MOVE EA 6314, Faculté des Sciences du Sport, Université de Poitiers, Poitiers, France.

Emeric Stauffer (E)

Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Team 'Vascular Biology and Red Blood Cell', Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.

Elisa Perger (E)

Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy.

Gianfranco Parati (G)

Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Samuel Verges (S)

HP2 Laboratory, Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, Avenue Kimberley, 38 434 Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH